NIH-funded research NIH-funded research

Understanding genetic variants in heart muscle cells

Official title: High-throughput functional characterization of MYH7 variants in genome-edited cardiomyocytes

Funded at VA Puget Sound Healthcare System · NIH-10928069 · Data updated 2026-11-12

This study is looking at how certain gene changes related to hypertrophic cardiomyopathy (HCM) affect heart cells, with the goal of helping doctors better understand and treat people with this condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Puget Sound Healthcare System
NIH-funded
Lab location1 site (Seattle, United States)
Project startApril 1, 2025
Project endMarch 31, 2029
Funding year2025
NIH project number1I01BX006428-01A1
Project IDNIH-10928069 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a family history of hypertrophic cardiomyopathy or those identified with MYH7 variants.

Less likely to help

Patients without any genetic predisposition to hypertrophic cardiomyopathy or those not carrying MYH7 variants may not benefit from this research.

What this research studies

This research focuses on hypertrophic cardiomyopathy (HCM), a genetic heart condition that can lead to serious complications like sudden cardiac death. It aims to clarify the effects of various genetic variants in the MYH7 gene, which are linked to HCM, using advanced gene-editing techniques on heart muscle cells derived from human stem cells. By creating detailed maps of how these genetic changes affect heart cell function, the research seeks to improve the diagnosis and management of patients with HCM. This approach could help identify individuals at risk and provide more personalized treatment options.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools for identifying patients at risk of developing hypertrophic cardiomyopathy.

How similar studies have gone: Previous research using similar gene-editing techniques in other conditions has shown promise, indicating potential for success in this novel application.

Where this research is happening

  • VA Puget Sound Healthcare System
    Seattle, United States
    Active

Researchers

  • Principal investigator: Yang, Kai-Chun Daniel — VA Puget Sound Healthcare System
  • Study coordinator: Yang, Kai-Chun Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.